Newsletter Subscription


Monday, July 6, 2015


Implant Sciences Receives Orders for QS-B220 Bench-Top Explosives and Narcotics Trace Detectors

  • New Product Launch Showing Early Success in China
Wilmington, MA - Implant Sciences Corporation (OTCQB: IMSC) (PINKSHEETS: IMSC), a high technology supplier of systems and sensors for homeland security markets, today announced it has received its first orders for the recently introduced Quantum Sniffer(TM) QS-B220 bench-top explosives and narcotics trace detector from China.

With over 800 units installed in numerous locations, the Company's QS-H150 portable explosives trace detector has gained significant market traction in China for a wide range of deployments across the country. Because of its increased sensitivity for explosives and its new narcotics detection capability, the QS-B220 extends the reach of Implant Sciences' product line, providing additional opportunity for new potential customers in security, customs, and corrections facilities.

Related Research on ASDReports.com:
Global Mass Transit Security Market 2014-2018

"The QS-B220 has received a very positive response from customers in China. We, and our Chinese distributors, believe the new Quantum Sniffer bench-top has the strong potential to meet and exceed the kind of sales levels we've seen in China for the QS-H150 portable unit. We anticipate that these units are just the beginning for the QS-B220," stated Glenn D. Bolduc, President and CEO of Implant Sciences.

Your company’s press release on ASDNews and to thousands of other journalists and editors? Use our ASDWire press release distribution service.

Source : Implant Sciences Corp.

Published on ASDNews: Oct 13, 2011

 

MilSatCom Latin America 2015 Conference

Sep 22 - 23, 2015 - Maceio, Brazil

Register More info


US Export Controls with REFORM CHANGES Seminar

Nov 2 - 5, 2015 - Phoenix, United States

Register More info


Air Mission Planning Conference

Jul 6 - 7, 2015 - London, United Kingdom

Register More info


© 2004-2015 • ASDNews • be the first to know • contact usterms & conditionsprivacy policyadvertisingfaqs

zpsk